US Patent Issued to Oncodesign on May 19 for "Macrocyclic RIP2-kinase inhibitors" (French, Spanish Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,563, issued on May 19, was assigned to Oncodesign S.A. (Dijon, France).

"Macrocyclic RIP2-kinase inhibitors" was invented by Yann Lamotte (Villebon sur Yvette, France), Nerina Dodic (Les Ulis cedex, France), Aurelien Tap (Saulx les Chartreux, France), Alexis Denis (Paris), Jean-Marie Brusq (Dampierre en Yvelines, France), Mourad Daoubi Khamlichi (Murcia, Spain) and Pascal Andre Rene Benderitter (St Apollinaire, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2-kinase, and/or mutants the...